CORRESP 1 filename1.htm

 

 

Katherine R. Kelly

 

Vice President & Assistant General Counsel

 

 

345 Park Avenue

New York, NY 10154-0037

 

Tel 212-546-4852

Fax 212-546-9966

 

katherine.kelly@bms.com

 

 

 

July 16, 2015

 

VIA EDGAR

 

Mr. Jim B. Rosenberg

Senior Assistant Chief Accountant

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

 

Re:                             Bristol-Myers Squibb Company

Form 10-K for the Year Ended December 31, 2014

Filed February 13, 2015

File No. 001-1136

 

Dear Mr. Rosenberg:

 

We have received the comment letter (the “Comment Letter”) dated July 8, 2015 regarding the comments of the staff of the Securities and Exchange Commission (the “Commission”) with respect to the above-referenced Form 10-K for the fiscal year ended December 31, 2014.  We are submitting this letter to confirm my conversation with your colleague, Rolf Sundwall today regarding the timing of our response to your comments.  As discussed with Mr. Sundwall, we anticipate providing a complete response by August 7, 2015.

 

 

Sincerely,

 

 

 

 

 

/s/ Katherine R. Kelly

 

Katherine R. Kelly

 

Vice President & Assistant General Counsel